Overview

Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of GenSci120 in Healthy Adult Participants in China.

Status:
RECRUITING
Trial end date:
2026-09-20
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the safety, tolerability, PK and PD of multiple subcutaneous injections of GenSci120 in a randomized, double-blind, placebo-controlled, multiple-ascending-dose phase Ib trial involving healthy adult participants.
Phase:
PHASE1
Details
Lead Sponsor:
Changchun GeneScience Pharmaceutical Co., Ltd.